AL
NVO

Airain Ltd’s Novo Nordisk NVO Stock Holding History

Airain Ltd’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-226,904
Closed -$4.72M – 794
2016
Q3 		$4.72M Buy
+226,904
New +$5.63M 0.28% 107
2016
Q2 		– Sell
-33,364
Closed -$904K – 821
2016
Q1 		$904K Buy
+33,364
New +$894K 0.06% 317

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Airain Ltd's NVO Position: Q4 2016 in Review

Airain Ltd sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 226,904 shares — an estimated $4.72M sold.

Airain Ltd first reported a position in NVO in Q1 2016 and held it in 2 quarters. The position peaked at $4.72M in Q3 2016. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • Airain Ltd reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
  • Airain Ltd sold 226,904 Novo Nordisk shares in Q4 2016, an estimated $4.72M.
  • Airain Ltd first reported a position in Novo Nordisk in Q1 2016 and held it in 2 quarters.
  • Airain Ltd's Novo Nordisk position peaked at $4.72M in Q3 2016.
  • 483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on Airain Ltd's 13F filing for Q4 2016, filed 10 Feb 2017.